Cellectar Biosciences Inc
$[[latestPrice]]
[[priceChange]]%
[[priceChange]]%
[[eodLastUpdatedDate]]
- [[key]] [[value]]
About
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Price Chart
Quarterly Results
(in millions, except per share amounts)
| [[ item.quarter ]] | |
|---|---|
| Revenue | [[ formatNumber(quarter.revenue) ]] |
| [[ (quarterExpenseStyle.display === 'none') ? 'Cost of Revenue +' : 'Cost of Revenue -' ]] | [[ formatNumber(quarter.costOfRevenue) ]] |
| Gross Margin | [[ formatNumber(quarter.grossMargin) ]] |
| [[ (quarterOperatingExpenseStyle.display === 'none') ? 'Operating Expense +' : 'Operating Expense -' ]] | [[ formatNumber(quarter.totalOperatingExpenses) ]] |
| Research and Development | [[ formatNumber(quarter.researchDevelopment) ]] |
| Selling, General and Administrative | [[ formatNumber(quarter.sellingGeneralAdministrative) ]] |
| Selling and Marketing Expenses | [[ formatNumber(quarter.sellingAndMarketingExpenses) ]] |
| Operating Income | [[ formatNumber(quarter.operatingIncome) ]] |
| OPM % | -[[ Math.floor(quarter.opm) ]]% |
| Other Income | [[ formatNumber(quarter.otherIncome) ]] |
| Interest | [[ formatNumber(quarter.interest) ]] |
| Depreciation | [[ formatNumber(quarter.depreciation) ]] |
| Income before Tax | [[ formatNumber(quarter.incomeBeforeTax) ]] |
| Tax % | -[[ Math.floor(quarter.taxPercentage) ]]% |
| Net Income | [[ formatNumber(quarter.netIncome) ]] |
| EPS (in $) | [[ formatNumber(quarter.eps) ]] |
Profit & Loss
(in millions, except per share amounts)
| [[ item.year ]] | |
|---|---|
| Revenue | [[ formatNumber(year.revenue) ]] |
| [[ (quarterExpenseStyle.display === 'none') ? 'Cost of Revenue +' : 'Cost of Revenue -' ]] | [[ formatNumber(year.costOfRevenue) ]] |
| Gross Margin | [[ formatNumber(year.grossMargin) ]] |
| [[ (quarterOperatingExpenseStyle.display === 'none') ? 'Operating Expense +' : 'Operating Expense -' ]] | [[ formatNumber(year.totalOperatingExpenses) ]] |
| Research and Development | [[ formatNumber(year.researchDevelopment) ]] |
| Selling, General and Administrative | [[ formatNumber(year.sellingGeneralAdministrative) ]] |
| Selling and Marketing Expenses | [[ formatNumber(year.sellingAndMarketingExpenses) ]] |
| Operating Income | [[ formatNumber(year.operatingIncome) ]] |
| OPM % | -[[ Math.floor(year.opm) ]]% |
| Other Income | [[ formatNumber(year.otherIncome) ]] |
| Interest | [[ formatNumber(year.interest) ]] |
| Depreciation | [[ formatNumber(year.depreciation) ]] |
| Income before Tax | [[ formatNumber(year.incomeBeforeTax) ]] |
| Tax % | -[[ Math.floor(year.taxPercentage) ]]% |
| Net Income | [[ formatNumber(year.netIncome) ]] |
| EPS (in $) | [[ formatNumber(year.eps) ]] |
| [[item.title]] | |
|---|---|
| [[ subItem.name ]]: | [[ subItem.val ]] |
Balance Sheet
(In millions, except number of shares, which are reflected in thousands, and par value)
| [[ item.year ]] | |
|---|---|
| [[ (balCurrentAssetsStyle.display === 'none') ? 'Current Assets +' : 'Current Assets -' ]] | [[ formatNumber(year.currentAssets) ]] |
| Cash and Equivalents | [[ formatNumber(year.cashAndEquivalents) ]] |
| Short Term Investments | [[ formatNumber(year.shortTermInvestments) ]] |
| Accounts receivable, net | [[ formatNumber(year.netReceivables) ]] |
| Inventories | [[ formatNumber(year.inventories) ]] |
| Other Current Assets | [[ formatNumber(year.otherCurrentAssets) ]] |
| [[ (balNonCurrentAssetsStyle.display === 'none') ? 'Non-Current Assets +' : 'Non-Current Assets -' ]] | [[ formatNumber(year.nonCurrentAssetsTotal) ]] |
| Long Term Investments | [[ formatNumber(year.longTermInvestments) ]] |
| Property Plant and Equipments | [[ formatNumber(year.propertyPlantAndEquipments) ]] |
| Other Non-Current Assets | [[ formatNumber(year.nonCurrentAssetsOther) ]] |
| GoodWill | [[ formatNumber(year.goodWill) ]] |
| Total Assets | [[ formatNumber(year.totalAssets) ]] |
| [[ (balCurrentLiabilitiesStyle.display === 'none') ? 'Current Liabilities +' : 'Current Liabilities -' ]] | [[ formatNumber(year.totalCurrentLiabilities) ]] |
| Accounts Payable | [[ formatNumber(year.accountsPayable) ]] |
| Other Current Liabilities | [[ formatNumber(year.otherCurrentLiabilities) ]] |
| Deferred Revenue | [[ formatNumber(year.deferredRevenue) ]] |
| [[ (balNonCurrentLiabilitiesStyle.display === 'none') ? 'Non-Current Liabilities +' : 'Non-Current Liabilities -' ]] | [[ formatNumber(year.nonCurrentLiabilities) ]] |
| Long Term Debt | [[ formatNumber(year.longTermDebt) ]] |
| Other Non-Current Liabilities | [[ formatNumber(year.nonCurrentLiabilitiesOther) ]] |
| Total Liabilities | [[ formatNumber(year.totalLiabilities) ]] |
Cash Flows
(In millions)
| [[ item.year ]] | |
|---|---|
| [[ (cashFlowOperatingStyle.display === 'none') ? 'Cash from Operating Activity +' : 'Cash from Operating Activity -' ]] | [[ formatNumber(year.cashFromOperatingActivities) ]] |
| Net Income | [[ formatNumber(year.netIncome) ]] |
| Depreciation | [[ formatNumber(year.depreciation) ]] |
| Accounts Receivable, net | [[ formatNumber(year.accountReceivables) ]] |
| Inventories | [[ formatNumber(year.inventories) ]] |
| Accounts Payable | [[ formatNumber(year.workingCapitalChanges) ]] |
| [[ (cashFlowInvestingStyle.display === 'none') ? 'Cash from Investing Activity +' : 'Cash from Investing Activity -' ]] | [[ formatNumber(year.cashFromInvestingActivities) ]] |
| Capital Expenditures | [[ formatNumber(year.capitalExpenditures) ]] |
| Investments | [[ formatNumber(year.investments) ]] |
| [[ (cashFlowFinancingStyle.display === 'none') ? 'Cash from Financing Activity +' : 'Cash from Financing Activity -' ]] | [[ formatNumber(year.cashFromFinancingActivities) ]] |
| Dividends Paid | [[ formatNumber(year.dividends) ]] |
| Repurchase of Stock | [[ formatNumber(year.repurchaseOfStock) ]] |
| Net Cash Flow | [[ formatNumber(year.netCashFlow) ]] |
Peer comparison
Sector: Healthcare Industry: Biotechnology
| [[ key ]] | |
|---|---|
| [[ item.name ]] | [[ value ]] |